Antifungal and cancer cell growth inhibitory activities of 1-(3′,4′,5′-trimethoxyphenyl)-2-nitro-ethylene

Mycoses

Volumn 45, Issue 3-4, 2002, Pages 65-74

  Pettit, R K ^a   Hamel, E ^b   Verdier Pinard, P ^b   Roberson, R W ^a   Hazen, K C ^c   Pettit, G R ^a   Crews, Laura C ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

1 (3 ,4 ,5 trimethoxyphenyl) 2 nitro ethylene; Anti cancer; Antifungal; Tubulin

Indexed keywords

1 (3',4',5' TRIMETHOXYPHENYL) 2 NITROETHYLENE; AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASIDIOMYCETES; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG CYTOTOXICITY; DRUG EFFECT; ENDOMYCETES; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; HUMAN; HUMAN CELL; HYPHOMYCETES; IC 50; MICROTUBULE ASSEMBLY; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; PH; PRIORITY JOURNAL;

ANIMALS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; BENZENE DERIVATIVES; BIOPOLYMERS; CELL DIVISION; ETHYLENES; FUNGI; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MICE; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; TUBULIN; TUMOR CELLS, CULTURED;

ANIMALIA; BASIDIOMYCOTA; CANDIDA; CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI; HYPHOMYCETES; MAMMALIA; MURINAE; SACCHAROMYCETES;

EID: 0036091631     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.2002.00722.x     Document Type: Article

References (24)

1. Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches
2. New and emerging yeast pathogens
3. Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action
4. Uber die anhalonium-alkaloide
5. Evaluation of antifungal activity of nyotran against various pathogenic fungi
6. Multicenter evaluation of a proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
7. In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives
8. Influence of test conditions on antifungal time-kill curve results: Proposal for standardized methods
9. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
10. Separation of active tubulin and microtubule-associated proteins by ultracentrifugation and isolation of a component causing the formation of microtubule bundles
11. Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells
12. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-90
13. In vitro preclincal evaluation studies with the echinocandin antifungal caspofungin (L-743,872)
14. Putative virulence factors of Candida albicans
15. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans
16. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds
17. Antimitotic natural products and their interactions with tubulin
18. Interaction of tubulin with single ring analogues of colchicine
19. Mescaline as a mitotic spindle inhibitor
20. Effects of inhibitors of tubulin polymerization on GTP hydrolysis
21. Tubulins: A target for antifungal agents